{
    "code": "02025918",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025918",
    "time": "2019-04-12 03:06:08",
    "許可證字號": "衛署藥輸字第025918號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/06\/27",
    "發證日期": "102\/06\/27",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202591807",
    "中文品名": "&quot;英特萊&quot;錠200毫克",
    "英文品名": "Intelence Tablets 200mg",
    "適應症": "INTELENCE與抗反轉錄病毒藥物併用，適用於曾有抗病毒藥物治療經驗，對過去的治療無效，且對NNRTI及其他抗反轉錄病毒藥物產生抗藥性之愛滋病毒HIV-1感染之成人患者。",
    "劑型": "110錠劑",
    "包裝": "4-1000錠塑膠瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "ETRAVIRINE"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1507401100  嬌生股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F250332200  JANSSEN-CILAG SPA",
        "製造廠廠址": "VIA C. JANSSEN, B.GO SAN MICHELE, 04100 LATINA, ITALY",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F050069000  JANSSEN PHARMACEUTICA N.V.",
            "製造廠廠址": "JANSSEN PHARMACEUTICALAAN 3, B-2440 GEEL, BELGIUM",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": "原料藥及中間產物製造廠"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0818004000",
            "成分名稱": "ETRAVIRINE",
            "含量描述": "",
            "含量": "200.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "INTELENCE英特萊錠200mg 中文仿單21x78cm-Hi-102-08-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025918&Seq=002&Type=9"
        },
        {
            "title": "Intelence 200mg_中文label-108-03-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025918&Seq=004&Type=8"
        },
        {
            "title": "Intelence-T1-200mg-box-980440_3-102-08-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025918&Seq=003&Type=8"
        }
    ]
}